We are live on ! Find out more
TWST icon

Twist Bioscience

245 hedge funds and large institutions have $2.99B invested in Twist Bioscience in 2024 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 92 increasing their positions, 77 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

193% more call options, than puts

Call options by funds: $5.94M | Put options by funds: $2.02M

19% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 77

0.55% less ownership

Funds ownership: 113.33%112.78% (-0.55%)

6% less funds holding

Funds holding: 262245 (-17)

8% less capital invested

Capital invested by funds: $3.25B → $2.99B (-$264M)

32% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 50

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
245
Holders Change
-17
Holders Change %
-6.49%
% of All Funds
3.52%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
34
Increased
92
Reduced
77
Closed
50
Calls
$5.94M
Puts
$2.02M
Net Calls
+$3.91M
Net Calls Change
-$1.05M
Name Holding Trade Value Shares
Change
Change in
Stake
Mariner
151
Mariner
Kansas
$397K +$106K +2,231 +34%
Neuberger Berman Group
152
Neuberger Berman Group
New York
$395K -$9.66K -203 -2%
CAM
153
ClariVest Asset Management
California
$363K
CG
154
Caprock Group
Idaho
$355K -$190 -4 -0.1%
Cerity Partners
155
Cerity Partners
New York
$354K +$373K +7,843 New
SRL
156
Scientech Research LLC
New Jersey
$342K -$1.14M -23,870 -76%
YC
157
Yarbrough Capital
Tennessee
$319K +$336K +7,068 New
MFIM
158
Mesirow Financial Investment Management
Illinois
$316K +$332K +6,984 New
HT
159
Headlands Technologies
Illinois
$315K +$93.1K +1,956 +39%
Stifel Financial
160
Stifel Financial
Missouri
$315K +$34.9K +734 +12%
PFM
161
Privium Fund Management
Netherlands
$314K +$115K +2,420 +53%
OSAM
162
O'Shaughnessy Asset Management
Connecticut
$292K +$298K +6,267 New
Pictet Asset Management
163
Pictet Asset Management
Switzerland
$288K -$29.8K -626 -9%
CCC
164
Chesapeake Capital Corp
Florida
$287K +$64.1K +1,347 +28%
TI
165
Tidal Investments
Wisconsin
$279K -$441K -9,270 -60%
MML Investors Services
166
MML Investors Services
Massachusetts
$277K -$314K -6,596 -52%
CAM
167
Cresset Asset Management
Illinois
$275K -$114K -2,391 -28%
Carson Wealth (CWM LLC)
168
Carson Wealth (CWM LLC)
Nebraska
$266K +$164K +3,457 +142%
AIP
169
Ameritas Investment Partners
Nebraska
$255K
KeyBank National Association
170
KeyBank National Association
Ohio
$255K +$70.8K +1,488 +36%
CC
171
Cypress Capital
Tennessee
$255K -$278K -5,835 -51%
Marshall Wace
172
Marshall Wace
United Kingdom
$239K +$251K +5,279 New
Public Employees Retirement Association of Colorado
173
Public Employees Retirement Association of Colorado
Colorado
$228K
GCP
174
GSA Capital Partners
United Kingdom
$226K -$41.9K -880 -15%
VPIM
175
Vanguard Personalized Indexing Management
California
$224K +$236K +4,959 New

TWST Hedge Fund Activity: Q3 2024 in Review

245 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Twist Bioscience (TWST) for Q3 2024, worth a combined $2.99B — down 8.1% from $3.25B a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of TWST and 34 opened new positions — a net loss of 16 holders — while 77 trimmed existing stakes and 92 added.

The largest buyer was Thrivent Financial for Lutherans, opening a new position worth an estimated $46.3M. The largest seller was ARK Investment Management, cutting an estimated $36.7M.

  • 245 institutional investors held Twist Bioscience (TWST) as of Q3 2024, down from 262 in Q2 2024.
  • Funds reported $2.99B of Twist Bioscience stock for Q3 2024, down 8.1% quarter-over-quarter.
  • 34 funds opened new Twist Bioscience positions in Q3 2024 and 50 closed out, a net change of -16 holders.
  • The largest Twist Bioscience buyer in Q3 2024 was Thrivent Financial for Lutherans, an estimated $46.3M added.
  • The largest Twist Bioscience seller in Q3 2024 was ARK Investment Management, an estimated $36.7M sold.

Based on aggregated 13F filings for Q3 2024.